About 50 results
Open links in new tab
  1. Encoded Therapeutics – Translating Next-Generation Science into ...

    Translating Next-Generation Science Into Transformative Gene Therapies Learn About Our Programs

  2. Programs – Encoded Therapeutics

    Programs Encoded is building an internally developed pipeline of best- and potentially first-in-class therapies focused on neurological disorders.

  3. About – Encoded Therapeutics

    Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Our diversity – whether gender, ethnicity, sexual …

  4. News – Encoded Therapeutics

    Press Releases January 12, 2026 Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome January 08, 2026 Encoded …

  5. Our Science – Encoded Therapeutics

    Ever wondered what it takes to make a gene therapy? Join us on a virtual lab tour at Encoded’s headquarters in South San Francisco. Meet a few of our talented scientists ready to explain what …

  6. Careers – Encoded Therapeutics

    Encoded offers competitive pay, an equity program and benefits. We provide the support that team members need at work to succeed, and we give back the benefits and perks to maintain their health …

  7. Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy ...

    Jan 12, 2026 · Encoded is advancing a pipeline of programs across genetic epilepsies and other neurological disorders with significant unmet need. With integrated discovery, development, and …

  8. Pipeline – Encoded Therapeutics

    This link leads outside the Encoded Therapeutics website and we are not responsible for that content.

  9. Contact – Encoded Therapeutics

    Contact Directory Patients Community and Clinical Trials [email protected] Healthcare Providers [email protected] Media [email protected] Finance/Accounting …

  10. Encoded Therapeutics Announces US IND Clearance and Australian …

    Encoded will be providing additional updates on its research pipeline, which is focused on both rare genetic and common disease programs, in addition to clinical progress with ETX101 for Dravet …